Moberg Pharma announces prospectus regarding admission to trading of new shares
STOCKHOLM, December 16th, 2016. The prospectus regarding the admission to trading of newly issued shares in Moberg Pharma AB (publ) (“Moberg Pharma”) is now available on the company’s website, www.mobergpharma.se, and in the company’s offices, at Gustavslundsvägen 42, 167 51 Bromma. Documents incorporated by reference in the prospectus are also available in accordance with the above.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, NEW ZEELAND, SOUTH AFRICA, HONG KONG OR SINGAPORE OR ANY OTHER JURISDICTION IN WHICH